Total Payments
$511,301
2024 Payments
$107,637
Companies
44
Transactions
773
Medicare Patients
6,949
Medicare Billing
$2.3M
Payment Breakdown by Category
Consulting$203,304 (39.8%)
Other$146,078 (28.6%)
Research$96,312 (18.8%)
Travel$41,158 (8.0%)
Food & Beverage$23,617 (4.6%)
Gifts$687.67 (0.1%)
Education$144.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $203,304 | 68 | 39.8% |
| Unspecified | $96,312 | 14 | 18.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $77,733 | 18 | 15.2% |
| Honoraria | $43,950 | 17 | 8.6% |
| Travel and Lodging | $41,158 | 111 | 8.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $24,395 | 5 | 4.8% |
| Food and Beverage | $23,617 | 534 | 4.6% |
| Gift | $687.67 | 3 | 0.1% |
| Education | $144.00 | 3 | 0.0% |
Payments by Type
General
$414,989
759 transactions
Research
$96,312
14 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Endo Pharmaceuticals Inc. | $108,492 | 52 | $0 (2022) |
| STRATA Skin Sciences, Inc. | $52,985 | 13 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $44,357 | 94 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $44,267 | 87 | $0 (2024) |
| VYNE Pharmaceuticals Inc. | $39,721 | 37 | $0 (2021) |
| Arcutis Biotherapeutics, Inc. | $37,471 | 35 | $0 (2024) |
| Medline Industries, Inc. | $36,512 | 41 | $0 (2021) |
| MIMEDX Group, Inc. | $32,920 | 15 | $0 (2024) |
| PFIZER INC. | $23,424 | 33 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $19,237 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $107,637 | 137 | MIMEDX Group, Inc. ($32,920) |
| 2023 | $80,525 | 80 | STRATA Skin Sciences, Inc. ($52,950) |
| 2022 | $59,125 | 45 | Endo Pharmaceuticals Inc. ($54,174) |
| 2021 | $26,015 | 79 | VYNE Pharmaceuticals Inc. ($20,085) |
| 2020 | $51,648 | 57 | Endo Pharmaceuticals Inc. ($24,610) |
| 2019 | $68,983 | 151 | Ortho Dermatologics, a division of Bausch Health US, LLC ($23,509) |
| 2018 | $44,650 | 108 | Ortho Dermatologics, a division of Bausch Health US, LLC ($15,490) |
| 2017 | $72,718 | 116 | MERZ NORTH AMERICA, INC. ($32,768) |
All Payment Transactions
773 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $8,029.00 | General |
| Category: ONCOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $4,588.00 | General |
| Category: ONCOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $1,147.00 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.85 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $461.35 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $105.90 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $97.89 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $76.40 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $39.41 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $39.41 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $35.52 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $42.07 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Immunology | ||||||
| 12/02/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,125.00 | General |
| 12/02/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,437.50 | General |
| 12/02/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| 12/02/2024 | MIMEDX Group, Inc. | — | Travel and Lodging | Cash or cash equivalent | $189.38 | General |
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.72 | General |
| Category: Immunology | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Consulting Fee | Cash or cash equivalent | $6,960.00 | General |
| 11/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $2,625.00 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2B, Open-Label Study to Explore Tissue Histopathology Following Subcutaneous Injection of Collagenase Clostridium Histolyticum Using An Abdominoplasty Model | Endo Pharmaceuticals Inc. | $54,145 | 2 |
| Not Specific to one study | Endo Pharmaceuticals Inc. | $39,781 | 11 |
| EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) | Eli Lilly and Company | $2,387 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,879 | 2,712 | $2.3M | $618,512 |
| 2022 | 25 | 1,792 | 2,429 | $2.3M | $621,099 |
| 2021 | 26 | 1,889 | 2,598 | $2.3M | $657,055 |
| 2020 | 23 | 1,389 | 2,223 | $1.5M | $412,101 |
Total Patients
6,949
Total Services
9,962
Medicare Billing
$2.3M
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 2 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 12 | 13 | $15,911 | $1,927 | 12.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 22 | $2,670 | $906.59 | 34.0% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 352 | 433 | $715,316 | $169,523 | 23.7% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 169 | 280 | $277,200 | $99,879 | 36.0% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2022 | 89 | 96 | $312,480 | $82,777 | 26.5% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2022 | 68 | 71 | $177,642 | $46,439 | 26.1% |
| 15240 | Full thickness skin graft to forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 20.0 sq cm or less | Office | 2022 | 46 | 48 | $153,504 | $38,811 | 25.3% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2022 | 30 | 33 | $102,234 | $26,319 | 25.7% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 47 | 53 | $78,440 | $26,228 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 248 | 352 | $69,624 | $25,346 | 36.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 188 | 188 | $48,504 | $17,504 | 36.1% |
| 14021 | Repair of wound of scalp, arms, or legs by transferring skin, 10.1-30.0 sq cm | Office | 2022 | 20 | 20 | $56,020 | $15,095 | 26.9% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 52 | 56 | $74,368 | $11,636 | 15.6% |
| 14020 | Repair of wound of scalp, arms, or legs by transferring skin, 10.0 sq cm or less | Office | 2022 | 13 | 13 | $29,770 | $7,945 | 26.7% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2022 | 20 | 22 | $21,890 | $7,513 | 34.3% |
| 15004 | Preparation of skin graft site of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less | Office | 2022 | 16 | 18 | $15,516 | $6,276 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $18,450 | $6,243 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 57 | $16,929 | $5,600 | 33.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 19 | 20 | $33,840 | $4,861 | 14.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 71 | 96 | $12,864 | $4,277 | 33.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 24 | 30 | $13,980 | $3,927 | 28.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 63 | 82 | $18,077 | $3,691 | 20.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 27 | 35 | $9,380 | $3,053 | 32.5% |
| 15271 | Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | Office | 2022 | 28 | 33 | $15,477 | $2,665 | 17.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 31 | 33 | $7,062 | $2,371 | 33.6% |
About Dr. Ashish Bhatia, M.D
Dr. Ashish Bhatia, M.D is a Dermatology healthcare provider based in Itasca, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073595690.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashish Bhatia, M.D has received a total of $511,301 in payments from pharmaceutical and medical device companies, with $107,637 received in 2024. These payments were reported across 773 transactions from 44 companies. The most common payment nature is "Consulting Fee" ($203,304).
As a Medicare-enrolled provider, Bhatia has provided services to 6,949 Medicare beneficiaries, totaling 9,962 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties MOHS-Micrographic Surgery, Procedural Dermatology
- Location Itasca, IL
- Active Since 11/18/2005
- Last Updated 02/25/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1073595690
Products in Payments
- XTRAC (Device) $52,985
- Zoryve (Drug) $26,808
- AMZEEQ (Drug) $25,497
- CIBINQO (Drug) $20,982
- LIBTAYO (Biological) $19,268
- ALTRENO (Drug) $19,120
- ZILXI (Drug) $14,224
- SILIQ (Drug) $12,531
- THERMAGE FLX $7,389
- QBREXZA (Drug) $6,072
- CELLUTOME (Device) $5,742
- KYBELLA (Biological) $4,560
- RETIN-A-MICRO (Drug) $4,458
- ARAZLO (Drug) $2,800
- TALTZ (Drug) $2,727
- RHOFADE (Drug) $2,397
- EUCRISA (Drug) $1,997
- BOTOX COSMETIC (Biological) $1,837
- Dermatology and Wound Care (Medical Supply) $1,679
- XEOMIN (Biological) $1,299
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.